146 related articles for article (PubMed ID: 27558534)
1. 4-Factor Prothrombin Complex Concentrate (PCC4, Kcentra®) Protocol Reduces Blood Requirements for Heart Transplantation: A Novel Protocol.
Pratt Cleary J; Hodge L; Palmer B; Barreiro CJ; Ingemi A
Ann Transplant; 2016 Aug; 21():531-7. PubMed ID: 27558534
[TBL] [Abstract][Full Text] [Related]
2. Case series of four-factor prothrombin complex concentrate for warfarin reversal before heart transplantation.
Nuckles KB; Pratt JH; Cameron CM; Ingemi AI
Transplant Proc; 2015 Apr; 47(3):841-3. PubMed ID: 25891743
[TBL] [Abstract][Full Text] [Related]
3. The use of prothrombin complex concentrate as a warfarin reversal agent in pediatric patients undergoing orthotopic heart transplantation.
Sisti DJ; Williams GD; Ding V; Long J; Maeda K; Chen S; Navaratnam M
Paediatr Anaesth; 2020 May; 30(5):564-570. PubMed ID: 32037665
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin Complex Concentrates for Warfarin Reversal Before Heart Transplantation.
Wanek MR; Hodges K; Persaud RA; Lam SW; Soltesz EG; Tong MZ; Moazami N
Ann Thorac Surg; 2019 May; 107(5):1409-1415. PubMed ID: 30476474
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of a Collaborative, Prospective Interdisciplinary Review and Pharmacy-Based Dispensing Process for Prothrombin Complex Concentrate.
Stratton M; Grgurich P; Heim K; Mackey S; Burns JD
Ann Pharmacother; 2018 May; 52(5):454-461. PubMed ID: 29310450
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.
Enter DH; Zaki AL; Marsh M; Cool N; Kruse J; Li Z; Andrei AC; Iddriss A; McCarthy PM; Malaisrie SC; Anderson A; Rich JD; Pham DT
Pharmacotherapy; 2017 Oct; 37(10):1215-1220. PubMed ID: 28833357
[TBL] [Abstract][Full Text] [Related]
7. Low-dose 3-factor prothrombin complex concentrate for warfarin reversal prior to heart transplant.
Kantorovich A; Fink JM; Militello MA; Wanek MR; Smedira NG; Soltesz EG; Moazami N
Ann Pharmacother; 2015 Aug; 49(8):876-82. PubMed ID: 25986007
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation.
Sun GH; Patel V; Moreno-Duarte I; Zahedi F; Ursprung E; Couper G; Chen FY; Welsby IJ; Comenzo R; Kao G; Cobey FC
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):161-167. PubMed ID: 29198634
[TBL] [Abstract][Full Text] [Related]
9. Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study.
Margraf DJ; Seaburg S; Beilman GJ; Wolfson J; Gipson JC; Chapman SA
BMC Emerg Med; 2020 Nov; 20(1):93. PubMed ID: 33243152
[TBL] [Abstract][Full Text] [Related]
10. Impact of Prothrombin Complex Concentrate on Blood Use, Cost, and Outcomes in Heart Transplantation.
Wu DW; Xia Y; Uelinger J; Forest S; Szymanski J; Mohandas K; Walsh R; Karim S; Marks E; Himchak E; Gupta R; Goldstein D
Ann Thorac Surg; 2018 Apr; 105(4):1152-1157. PubMed ID: 29397934
[TBL] [Abstract][Full Text] [Related]
11. Pre-emptive intraoperative administration of PCC4 in cardiac surgery patients at high risk of bleeding: A pilot study.
Elder J; McComb J; Lirette S; Herndon B; Yancey G; Mohammed A; Copeland H
J Card Surg; 2022 Dec; 37(12):5130-5134. PubMed ID: 36423240
[TBL] [Abstract][Full Text] [Related]
12. Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate.
Jansma B; Montgomery J; Dietrich S; Mixon MA; Peksa GD; Faine B
Ann Pharmacother; 2020 Nov; 54(11):1090-1095. PubMed ID: 32418445
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal in Patients with Intracranial Hemorrhage.
Scott R; Kersten B; Basior J; Nadler M
J Emerg Med; 2018 Jun; 54(6):861-866. PubMed ID: 29510892
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.
Hickey M; Gatien M; Taljaard M; Aujnarain A; Giulivi A; Perry JJ
Circulation; 2013 Jul; 128(4):360-4. PubMed ID: 23770745
[TBL] [Abstract][Full Text] [Related]
15. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
Sin JH; Berger K; Lesch CA
J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
17. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
Rimsans J; Levesque A; Lyons E; Sylvester K; Givertz MM; Mehra MR; Stewart GC; Connors JM
J Thromb Thrombolysis; 2018 Aug; 46(2):180-185. PubMed ID: 29785470
[TBL] [Abstract][Full Text] [Related]
18. Comparison of blood product use and costs with use of 3-factor versus 4-factor prothrombin complex concentrate for off-label indications.
DeAngelo J; Jarrell DH; Cosgrove R; Camamo J; Edwards CJ; Patanwala AE
Am J Health Syst Pharm; 2018 Aug; 75(15):1103-1109. PubMed ID: 29941507
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 3-factor versus 4-factor prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis.
Margraf DJ; Brown SJ; Blue HL; Bezdicek TL; Wolfson J; Chapman SA
BMC Emerg Med; 2022 Jan; 22(1):14. PubMed ID: 35073849
[TBL] [Abstract][Full Text] [Related]
20. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
